Transcend Capital Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Sell |
18,275
-34,616
| -65% | -$2.42M | 0.1% | 185 |
|
|
2025
Q1 | $3.89M | Sell |
52,891
-19,729
| -27% | -$1.45M | 0.28% | 81 |
|
|
2024
Q4 | $4.76M | Sell |
72,620
-5,397
| -7% | -$354K | 0.34% | 65 |
|
|
2024
Q3 | $6.08M | Buy |
78,017
+105
| +0.1% | +$8.18K | 0.41% | 56 |
|
|
2024
Q2 | $6.08M | Buy |
77,912
+56,397
| +262% | +$4.4M | 0.44% | 48 |
|
|
2024
Q1 | $1.46M | Buy |
+21,515
| New | +$1.46M | 0.12% | 182 |
|
|
2023
Q3 | – | Sell |
-2,967
| Closed | -$212K | – | 490 |
|
|
2023
Q2 | $212K | Sell |
2,967
-254
| -8% | -$18.2K | 0.02% | 449 |
|
|
2023
Q1 | $224K | Sell |
3,221
-1,224
| -28% | -$85K | 0.02% | 426 |
|
|
2022
Q4 | $301K | Sell |
4,445
-416
| -9% | -$28.2K | 0.03% | 362 |
|
|
2022
Q3 | $267K | Sell |
4,861
-787
| -14% | -$43.2K | 0.03% | 383 |
|
|
2022
Q2 | $373K | Buy |
5,648
+203
| +4% | +$13.4K | 0.04% | 341 |
|
|
2022
Q1 | $361K | Buy |
5,445
+138
| +3% | +$9.15K | 0.03% | 372 |
|
|
2021
Q4 | $309K | Buy |
5,307
+776
| +17% | +$45.2K | 0.03% | 381 |
|
|
2021
Q3 | $282K | Sell |
4,531
-6
| -0.1% | -$373 | 0.03% | 387 |
|
|
2021
Q2 | $271K | Sell |
4,537
-2,388
| -34% | -$143K | 0.04% | 271 |
|
|
2021
Q1 | $346K | Buy |
6,925
+1,691
| +32% | +$84.5K | 0.04% | 290 |
|
|
2020
Q4 | $262K | Buy |
+5,234
| New | +$262K | 0.03% | 313 |
|